非传统的成功:在重复性高度子宫内膜癌肉瘤中,用 pembrolizumab 实现长期缓解
Anaiya G Singh1, Viraj S Panchal2, Suvarna Guvvala3
1Department of Internal Medicine, LSU Health Shreveport, 1541 Kings Hwy, Shreveport, LA 71103, United States.
Gynecologic oncology reports
|May 1, 2025
概括
在患有复发性,高度,微卫星稳定的子宫内膜癌的患者中, pembrolizumab 诱导了长期缓解. 这一发现表明免疫疗法可能对这种罕见的癌症有效,挑战目前的治疗方法.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 妇科瘤学 妇科瘤学
背景情况:
- 子宫内膜癌是一种罕见且具有攻击性的子宫恶性瘤.
- 微卫星稳定 (MSS) 亚型通常对传统疗法反应有限.
- 复发性疾病带来了严重的治疗挑战,预后不佳.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.0K
03:01Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
Published on: August 2, 2024
487
